Database
Funding Rounds
736 rounds tracked
A general-purpose industrial embodied AI platform company developing end-to-end embodied intelligence control technology for industrial robots. The company creates wheeled humanoid dual-arm robots (TX01) for flexible material handling, loading/unloading, precision assembly, and quality inspection in industrial scenarios.
Hongde Investment, Shengshi Hongyuan
Source →A leading invasive brain-computer interface company in China that develops flexible electrodes, neural signal acquisition chips, decoding algorithms, and electrode implantation robots for high-bandwidth information exchange between the human brain and external devices.
China Science Star Capital, Shunwei Capital, Yuansheng Ventures +more
Source →An embodied AI company that develops humanoid robots for industrial applications, particularly for battery manufacturing and assembly tasks.
A low-altitude economy company developing eVTOL (electric vertical takeoff and landing) aircraft, specifically the AE200 six-seat tiltrotor model for urban air mobility, low-altitude tourism, and emergency rescue applications.
CITIC Securities, National Strategy Investment, Ascendent Capital Partners +more
Source →A high-tech enterprise developing embodied AI technology and humanoid robot products with core capabilities in VLM+VLA+VLN brain models for industrial automation and flexible manufacturing applications.
Ningbo Industrial Internet Research Institute, Haifu Holdings Group +more
Source →A small nucleic acid (siRNA) drug company developing innovative RNA interference therapeutics. The company has developed proprietary hepatic-targeting RiboGalSTAR delivery technology and has multiple products in clinical stage development.
Dacheng Fund, Huaxia Fund
Source →A company focused on converting fundamental scientific discoveries into future energy industry with strategic value, developing controlled nuclear fusion technology based on magnetic zero-point configuration fusion pathway with potential for low-cost, high-performance fusion energy.
Xishan Angel Club, Peking University Science and Technology Development Department Yanyuan Incubator
Source →A high-end ancient technique gold jewelry brand specializing in filigree inlay craftsmanship, featuring palace techniques with a 3000-year history and positioning itself as luxury jewelry comparable to international brands.
Challenger Fund, Kering Group
Source →A semiconductor chip design company spun off from NIO that develops autonomous driving chips for electric vehicles, including the NX9031 and M97 chips, collaborating with other automakers through technology licensing.
OmniVision Integrated Circuits, Aicore Intelligence
Source →A thermal management solutions provider specializing in immersion liquid cooling technology for high-power density applications including EV charging, battery energy storage, AI data centers, and power electronics.
Hangzhou Science and Innovation Group, Wanxiang Group
Source →Shuzian develops enterprise-grade Data Agent solutions that integrate heterogeneous data sources and leverage large language models to enable automated data analysis, intelligent report generation, and business decision support for enterprises.
Wealth Fund, Jihe Ventures, Beijing Information Industry Development Investment Fund, Shanghai Lingyi Investment +more
Source →An AI-powered investment research platform that uses AI technology to assist institutional investors with research tasks, offering products like AI meeting minutes assistant and AI agent matrix for investment analysis.
Gaotu Techedu Ventures, Jiacheng Capital, Zhongding Capital
Source →Xingyi Intelligent is a physical AI data infrastructure company incubated from Tsinghua University, focusing on first-person real interaction data and full-stack data infrastructure for embodied AI.
Lingun Light, Shunxi Fund, First Venture Capital
Source →Yuanshi Technology is an early-stage company focusing on AI Virtual Cell (AIVC) technology, building a vertical life science foundation with a biological raw data engine and general cellular models for drug discovery and life science applications.
Yanyuan Venture Capital
Source →Beyond Biomaterials is an innovative biomaterials company driven by synthetic biology and artificial intelligence, focusing on the R&D and industrialization of recombinant proteins and novel functional biomolecules for beauty, healthcare, and nutrition.
Guangxin Holdings Fund, L'Oréal BOLD Fund, VentureCanvas, Junke Danmu +more
Source →RuiChu Pharma is an innovative enterprise targeting aging biology and developing 'Senotherapeutics' to treat aging-related diseases. The company builds differentiated pipelines covering multiple disease fields based on platforms designed to clear, activate, and reprogram senescent cells.
Forte Capital, Huatai GenScript
Source →Neolix is a Chinese company that manufactures autonomous delivery vehicles for commercial and logistics applications.
China’s National Artificial Intelligence Industry Investment Fund
Source →YITA is a robot hardware startup that develops advanced robotic systems.
SenseTime Guoxiang Capital, Fourier
Source →Liman Biology focuses on high-throughput cell editing and perturbed sample data production, serving as a data infrastructure supplier for the artificial intelligence virtual cell (AIVC) industry.
Runmiao Fund
Source →Gewu Tongzhi develops artificial intelligence for dexterous robotic manipulation, combining world models with learning from physical environments.
Hongfu Asset Management, Hangzhou Talent Group
Source →SciVisual is a scientific simulation and AI-data startup that converts complex scientific data and processes into visual simulations.
Ruoyu Technology focuses on the research and development of embodied AI robot brains and scenario-based applications, building a full-stack delivery closed-loop from base models and reliable hardware to high-value scenarios.
Sunway Communication, Huanghai Capital, Jinmu Capital +more
Source →InfiMaker develops compact five-axis computer numerical control machines for professional users and creators.
High Dimension Medicine is a biotechnology company leveraging high-dimensional biology and AI-driven drug discovery platforms to develop first-in-class and best-in-class therapies for neurodegenerative diseases, oncology, and other major diseases.
orient fortune capital, Huatai GenScript Biotech Fund, Ruili Investment, Xihu Innovation +more
Source →